Literature DB >> 24338289

Hyperglycemia at admission and during hospital stay are independent risk factors for mortality in high risk cardiac patients admitted to an intensive cardiac care unit.

J A Lipton1, R J Barendse, R T Van Domburg, A F L Schinkel, H Boersma, M I Simoons, K M Akkerhuis.   

Abstract

AIMS: Hyperglycemia is associated with increased mortality in cardiac patients. However, the predictive value of admission- and average glucose levels in patients admitted to an intensive cardiac care unit (ICCU) has not been described.
METHODS: Observational study of patients admitted to the ICCU of a tertiary medical center in whom glucose levels were measured at and during admission. Over a 19-month period, 1713 patients were included. Mean age was 63±14 years, 1228 (72%) were male, 228 (17%) had known diabetes. Median (interquartile) glucose levels at admission were 7.9 (6.5-10.1) mmol/l; median glucose levels during ICCU admission (873 patients with three or more measurements) were 7.3 (6.7-8.3) mmol/l. Cox regression analysis was performed including the variables age, gender, admission diagnosis, length of stay, prior (cardio)vascular disease and diabetes.
RESULTS: A 1 mmol/l increase in admission glucose level (above 9 mmol/l) was associated with a 10% (95% confidence interval (CI): 7 -13%) increased risk for all-cause mortality. A 1 mmol/l higher average glucose level (above 8 mmol/l) was an additional independent predictor of mortality (HR 1.11, 95% CI: 1.03 - 1.20). At 30 days, 16.8% (97/579) of the patients with an admission glucose level in the highest tertile (>9.8 mmol/L) had died vs 5.2% (59/1134) of those with a lower admission glucose level.
CONCLUSION: In a high risk ICCU population, both high admission glucose levels as well as high average glucose levels during hospitalization were independently associated with increased mortality, even when accounting for other risk factors and parameters of disease severity.

Entities:  

Keywords:  Glucose levels; acute coronary syndrome; intensive cardiac care; prognosis

Mesh:

Substances:

Year:  2013        PMID: 24338289      PMCID: PMC3821826          DOI: 10.1177/2048872613489304

Source DB:  PubMed          Journal:  Eur Heart J Acute Cardiovasc Care        ISSN: 2048-8726


  22 in total

1.  Blood glucose area under the curve. Methodological aspects.

Authors:  J P Le Floch; P Escuyer; E Baudin; D Baudon; L Perlemuter
Journal:  Diabetes Care       Date:  1990-02       Impact factor: 19.112

2.  Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study.

Authors:  K Malmberg; A Norhammar; H Wedel; L Rydén
Journal:  Circulation       Date:  1999-05-25       Impact factor: 29.690

Review 3.  Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview.

Authors:  S E Capes; D Hunt; K Malmberg; H C Gerstein
Journal:  Lancet       Date:  2000-03-04       Impact factor: 79.321

4.  Impact of an alerting clinical decision support system for glucose control on protocol compliance and glycemic control in the intensive cardiac care unit.

Authors:  Jonathan A Lipton; Rogier J Barendse; Arend F L Schinkel; K Martijn Akkerhuis; Maarten L Simoons; Eric J G Sijbrands
Journal:  Diabetes Technol Ther       Date:  2011-02-03       Impact factor: 6.118

Review 5.  Metabolic causes and prevention of ventricular fibrillation during acute coronary syndromes.

Authors:  Michael F Oliver
Journal:  Am J Med       Date:  2002-03       Impact factor: 4.965

6.  Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study.

Authors:  Mahmoud Suleiman; Haim Hammerman; Monther Boulos; Michael R Kapeliovich; Abeer Suleiman; Yoram Agmon; Walter Markiewicz; Doron Aronson
Journal:  Circulation       Date:  2005-02-07       Impact factor: 29.690

7.  Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era?

Authors:  Nazneem N Wahab; Elizabeth A Cowden; Neil J Pearce; Martin J Gardner; Heather Merry; Jafna L Cox
Journal:  J Am Coll Cardiol       Date:  2002-11-20       Impact factor: 24.094

8.  Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study.

Authors:  Anna Norhammar; Ake Tenerz; Göran Nilsson; Anders Hamsten; Suad Efendíc; Lars Rydén; Klas Malmberg
Journal:  Lancet       Date:  2002-06-22       Impact factor: 79.321

9.  Automatic calculation of a modified APACHE II score using a patient data management system (PDMS).

Authors:  Axel Junger; Sebastian Böttger; Jörg Engel; Matthias Benson; Achim Michel; Rainer Röhrig; Andreas Jost; Gunter Hempelmann
Journal:  Int J Med Inform       Date:  2002-06       Impact factor: 4.046

10.  Relation between plasma free fatty acids and arrhythmias within the first twelve hours of acute myocardial infarction.

Authors:  M J Tansey; L H Opie
Journal:  Lancet       Date:  1983-08-20       Impact factor: 79.321

View more
  9 in total

1.  Relationship between admission blood glucose level and prognosis in elderly patients without previously known diabetes who undergo emergency non-cardiac surgery.

Authors:  Jinling Ma; Lei He; Xiujie Wang; Meng Gao; Yuexiang Zhao; Jie Liu
Journal:  Intern Emerg Med       Date:  2015-01-24       Impact factor: 3.397

2.  Outcomes of Less Intensive Glycemic Target for a Subcutaneous Insulin Protocol in Hospitalized Patients.

Authors:  Gagandeep Kaur; Brandon Markley; Karen Schlauch; Kenneth E Izuora
Journal:  Am J Med Sci       Date:  2015-12       Impact factor: 2.378

3.  Influence of a strict glucose protocol on serum potassium and glucose concentrations and their association with mortality in intensive care patients.

Authors:  Esther V Uijtendaal; Jeannette E F Zwart-van Rijkom; Dylan W de Lange; Arief Lalmohamed; Wouter W van Solinge; Toine C G Egberts
Journal:  Crit Care       Date:  2015-06-22       Impact factor: 9.097

4.  Diabetes mellitus exacerbates post-myocardial infarction heart failure by reducing sarcolipin promoter methylation.

Authors:  Zhongwei Liu; Yong Zhang; Chuan Qiu; Haitao Zhu; Shuo Pan; Hao Jia; Hongyan Kang; Gongchang Guan; Rutai Hui; Ling Zhu; Junkui Wang
Journal:  ESC Heart Fail       Date:  2020-06-11

Review 5.  Role of Tight Glycemic Control during Acute Coronary Syndrome on CV Outcome in Type 2 Diabetes.

Authors:  Ferdinando Carlo Sasso; Luca Rinaldi; Nadia Lascar; Aldo Marrone; Pia Clara Pafundi; Luigi Elio Adinolfi; Raffaele Marfella
Journal:  J Diabetes Res       Date:  2018-10-04       Impact factor: 4.011

6.  The Effect of Glycemic Control on Endothelial and Cardiac Dysfunction Induced by Red Blood Cells in Type 2 Diabetes.

Authors:  Ali Mahdi; Tong Jiao; Jiangning Yang; Oskar Kövamees; Michael Alvarsson; Maaria von Heijne; Zhichao Zhou; John Pernow
Journal:  Front Pharmacol       Date:  2019-08-02       Impact factor: 5.810

7.  Selective protein kinase C inhibition switches time-dependent glucose cardiotoxicity to cardioprotection.

Authors:  Sean Brennan; Simona Esposito; Muhammad I M Abdelaziz; Christopher A Martin; Samir Makwana; Mark W Sims; Iain B Squire; Parveen Sharma; Amy E Chadwick; Richard D Rainbow
Journal:  Front Cardiovasc Med       Date:  2022-09-07

Review 8.  COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course.

Authors:  Cyril P Landstra; Eelco J P de Koning
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-17       Impact factor: 5.555

9.  Hyperglycemia-induced diaphragm weakness is mediated by oxidative stress.

Authors:  Leigh A Callahan; Gerald S Supinski
Journal:  Crit Care       Date:  2014-05-03       Impact factor: 9.097

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.